← Back to Search

Transcranial Electric Stimulation

Brain Stimulation for Improving Working Memory (TravelingTES Trial)

N/A
Recruiting
Led By Ivan Alekseichuk, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18 and 45 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five minutes post-stimulation
Awards & highlights

TravelingTES Trial Summary

This trial will test if a brain stimulation technique can improve working memory in adults.

Who is the study for?
This trial is for adults aged 18-45 with a good grasp of English. It's not suitable for those with chronic neurological or mental disorders, head injuries causing unconsciousness, ongoing medical conditions needing drugs, pregnant or breastfeeding individuals, substance addicts, or people with metal/electric implants in the upper body.Check my eligibility
What is being tested?
The study is testing how traveling-wave transcranial electric stimulation (tACS), a non-invasive brain stimulation technique, affects working memory performance in healthy adults.See study design
What are the potential side effects?
Possible side effects of tACS may include mild headaches, itching or tingling at the electrode sites during stimulation. More serious risks are rare but can include seizures and other neurological symptoms.

TravelingTES Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old.

TravelingTES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate effect during stimulation
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate effect during stimulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in working memory performance
Secondary outcome measures
Changes in electroencephalographic (EEG) connectivity
Changes in reaction time

TravelingTES Trial Design

4Treatment groups
Experimental Treatment
Group I: Parietofrontal Slow Theta StimulationExperimental Treatment1 Intervention
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Group II: Parietofrontal Fast Theta StimulationExperimental Treatment1 Intervention
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces parietal-to-frontal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.
Group III: Frontoparietal Slow Theta StimulationExperimental Treatment1 Intervention
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 4 Hz with the intensity of up to 2 mA and duration up to 20 min.
Group IV: Frontoparietal Fast Theta StimulationExperimental Treatment1 Intervention
Participants will receive multi-electrode transcranial alternating current stimulation over the prefrontal and parietal brain regions that induces frontal-to-parietal traveling wave at the frequency of 7 Hz with the intensity of up to 2 mA and duration up to 20 min.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,371 Previous Clinical Trials
1,588,057 Total Patients Enrolled
1 Trials studying Working Memory
16 Patients Enrolled for Working Memory
Brain & Behavior Research FoundationOTHER
61 Previous Clinical Trials
2,790 Total Patients Enrolled
Ivan Alekseichuk, PhDPrincipal InvestigatorUniversity of Minnesota

Media Library

Transcranial Alternating Current Stimulation (tACS) (Transcranial Electric Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05399381 — N/A
Working Memory Research Study Groups: Parietofrontal Fast Theta Stimulation, Frontoparietal Fast Theta Stimulation, Parietofrontal Slow Theta Stimulation, Frontoparietal Slow Theta Stimulation
Working Memory Clinical Trial 2023: Transcranial Alternating Current Stimulation (tACS) Highlights & Side Effects. Trial Name: NCT05399381 — N/A
Transcranial Alternating Current Stimulation (tACS) (Transcranial Electric Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05399381 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can the trial accommodate?

"Affirmative. Clinicaltrials.gov's records suggest that this clinical trial is currently recruiting for candidates, which began on September 5th 2022 and was recently updated on October 4th 2022. The study requires 24 patients from a sole research centre to participate."

Answered by AI

Is there a possibility for me to partake in this research program?

"This medical trial is currently recruiting 24 individuals aged between 18 and 45 who possess working memory. In addition, they must demonstrate an adequate grasp of the English language to qualify for participation."

Answered by AI

Is there a minimum age requirement to take part in the experiment?

"According to the specified parameters of this clinical trial, prospective participants must be aged between 18 and 45."

Answered by AI

Is this experiment currently recruiting participants?

"Indeed, the information displayed on clinicaltrials.gov implies that this medical trial is recruiting patients. This study was initially published on September 5th 2022 and has been modified most recently on October 4th 2022. The project needs 24 participants located in one area of the country."

Answered by AI
~8 spots leftby Dec 2024